Mycoplasma - Often Overlooked In Chronic Lyme Disease

[Guest guest]

Mycoplasma - Often Overlooked In Chronic Lyme Disease

_http://www.publichealthalert.org/Articles/scottforsgren/mycoplasma.htm_

(http://www.publichealthalert.org/Articles/scottforsgren/mycoplasma.htm)

by Scott Forsgren

 

Those of us with chronic Lyme disease are quite familiar with the names of

the better known Lyme co-infections. Babesia, Bartonella, and Ehrlichia

have become everyday words. As much as we would like to rid ourselves of

these illness-producing pathogens, they have become a part of our daily

struggle to regain a sense of health and wellness. Unfortunately, these are not

the only co-infections seen in chronic Lyme disease. For some reason,

Mycoplasma infections are not only lesser known by patients, but seemingly

often

overlooked by doctors as well. It is important for us, as patients, to

educate ourselves on the topic of Mycoplasma and to ask our practitioners how

we

are being evaluated and treated for these infections.

In 1987, Dr. Garth Nicolson, PhD was a professor at the University of

Texas at Houston when his wife, an instructor at Baylor College of Medicine,

became seriously ill and nearly died. She was diagnosed with a Mycoplasma

infection, treated, and later recovered. A few years later, their daughter,

who had served in the Gulf War, returned from active duty quite ill. Not only

was she sick, but the symptoms that she exhibited were very similar to

those that Dr. Nicolson's wife had expressed years earlier.

 

At that point, Dr. Nicolson had the idea that his daughter's illness could

be the result of an infection and started to investigate his theory

further. As his work progressed, he looked at Brucella, Borrelia, Ehrlichia,

and

other chronic intracellular infections that have the potential to cause

illness and present with overlapping signs and symptoms. In Gulf War veterans

that were being evaluated, approximately 45% of those that were ill had

Mycoplasma infection. It was found that the infection was a particular type of

Mycoplasma, namely a peculiar species called Mycoplasma fermentans.

Very little was known about this particular species of Mycoplasma at the

time except that the Armed Forces Institute of Pathology and the Army had

been doing research on the organism. Once this likely causative agent of Gulf

War Illness (GWI) had been identified in about one-half of the GWI cases,

Dr. Nicolson recommended that the Mycoplasma-infected Gulf War veterans be

treated with Doxycycline. He then found himself the target of vicious

attacks for making the connection between the illness and M. fermentans. Dr.

Nicolson shared that " even talking about this organism was highly

discouraged. " In fact, until the Gulf War, the military's own medical school

had been

teaching about the dangers of M. fermentans for years.

 

Background

 

Just years earlier in Texas, prisons emerged in which many of the inmates

and guards came down with neurodegenerative conditions at rates that were

far from ordinary. In Huntsville, where three large State prisons are found,

there were about 70 cases of ALS, numerous cases of Multiple Sclerosis,

and highly unexpected numbers of Rheumatoid Arthritis cases. At that time,

the term " Mystery Disease " was used to identify the unusual illnesses that so

many seemed to have acquired.

Dr. Nicolson started testing prison guards and their family members and

found that very high numbers of these people were testing positive for

Mycoplasma fermentans. Furthermore, this appeared to be a weaponized version of

the organism called M. fermentans incognitus, a specific strain of

Mycoplasma that had been altered to cause more severe symptoms, to be more

virulent,

and to be more survivable than the naturally occurring M. fermentans. Dr.

Nicolson believed that biological weapons experiments had been carried out

on inmates in the Texas prison system for years in which humans had been

used as guinea pigs.

As time progressed, these illnesses did not remain confined to the

prisoners. Soon after the prisoners unknowingly became a part in these

experiments, the prison guards became ill. Their illnesses gradually became

those of

their families. It was not long before these Mycoplasma-based illnesses

became a broader part of the surrounding Huntsville, Texas landscape.

 

The Texas prisoners that came down with Amyotrophic Lateral Sclerosis

(ALS) later died. In the state of Texas, at the time, the state law dictated

that all prisoners that died were later to be autopsied at University of

Texas at Galveston. However, that was not what was happening to the prisoners

who had died as a result of this horrific experimentation, according to Dr.

Nicolson. Through one of his former students who at the time was responsible

for the autopsy service at UT Galveston, Dr. Nicolson learned that none of

the bodies had been sent there. Dr. Nicolson had discovered that at least

six private autopsies a week were being performed on deceased prisoners at

a US Army base. The bodies were then sent to a private crematory at a

secret location in central Texas. Additionally, prisoner records were

destroyed.

All of this, according to Dr. Nicolson, violated state law.

 

Though much of the evidence of this experimentation had been destroyed, a

document was found in the basement of an Austin building that was viewed as

the " smoking gun " . The document indicated that the Texas Prison Board,

Baylor College of Medicine, and the Department of Defense were all a part of

the experiments involving the Texas prisoners - experiments that later

resulted in the death of many of the inmates. According to Dr. Nicolson, some

of

the experiments used Mycoplasma while others utilized various " cocktails of

microbial agents " such as Mycoplasma, Brucella, and DNA viruses such as

Parvovirus B19. This project later became the topic of a book by Dr.

Nicolson entitled Project Day Lily.

 

Dr. Nicolson believes that Mycoplasma fermentans is a naturally occurring

microbe. However, some of the strains that exist today have been

weaponized. Dr. Nicolson's research found unusual genes in M. fermentans

incognitus

that were consistent with a weaponized form of the organism. Weaponzing of

an organism is done in an attempt to make a germ more pathogenic,

immunosuppressive, resistant to heat and dryness, and to increase its survival

rate

such that the germ could be used in various types of weapons. Genes which

were part of the HIV-1 envelope gene were found in these Mycoplasma. This

means that the infection may not give someone HIV, but that it may result in

some of the debilitating symptoms of the HIV disease. Indicators of a

weaponized organism were evident in the prison guards in Huntsville as well as

in

military personnel that were likely exposed to the infections both through

military vaccinations as well as through weapons used in the Gulf War.

 

The unfortunate reality according to Dr. Nicolson is that " once these

things get out, you can't put the genie back in the bottle " . Once these germs

have been released, they are airborne infections that slowly penetrate into

the population. In the case of Mycoplasma fermentans, Dr. Nicolson believes

that this is exactly what happened. It may be this weaponized form of

Mycoplasma that has led to the significant increases in neurodegenerative and

autoimmune diseases over the last several years. Those patients with

weaponized strains of these organisms are generally very sick. They may

experience

60-75 signs and symptoms and are even at risk of their diseases becoming

fatal.

 

In looking at the source of infection in the Gulf War veterans who were

contracting Mycoplasma, Dr. Nicolson suggests that vaccinations appear to be

the most likely mechanism through which the veterans became infected. Many

military personnel that later became ill were far from the battlefields or

had received the vaccinations and were never deployed. However, biological

weapons sprayers were known to have been deployed by the Iraqis in the Gulf

War and were used to spray the sand in Iraq and Kuwait. Gerald Schumacher,

a Special Forces colonel in charge of biological weapons detection, blew

the whistle on this after he retired. During the Gulf War, his group was not

allowed to deploy their biological weapons detectors which led to reports

that no such weapons were detected or used.

The Iraqis received a great deal of assistance on biological warfare from

the United States during the Iran-Iraq Conflict. Both chemical and biologic

weapons were given to them from the United States. After the Gulf War,

rather than taking inventory of these weapons, they were blown up. Dr. Nicolson

indicates that some of his patients have taken videos standing next to

crates with Hazardous Materials tags from the United States. In the same

videos, the crates are opened and weapons are clearly striped as having

originated from the United States and being both chemical and biological

weapons.

 

There were clear indicators that Iraq had offensive weapons in their

arsenal. In Kuwait, many people had become quite ill. It was estimated that 25%

of the population after the Gulf War had signs and symptoms which matched

the symptoms of those infected with weaponized Mycoplasma. There were also a

number of other chemical exposures and thus, there was never a clear

indicator as to whether or not the Iraqi illnesses were caused by biologic or

chemical agents.

 

When asking Dr. Nicolson how much he personally has been harassed for

bringing much of this information to light, he shared that it has been " a

horrific time " . After Dr. Nicolson exposed the Huntsville prison experiments,

the University of Texas educational system attempted to fire him from his

tenured and highly respected position. Dr. Nicolson shared that a tremendous

amount of pressure was put on the University of Texas system to " shut him up

and close his laboratory " . He was threatened on an almost daily basis with

closing his lab as he continued to do his research on Mycoplasma. This

became a major subject in the book Project Day Lily. Fortunately, for many of

us struggling with chronic illnesses, Dr. Nicolson's experience and

knowledge continue to be a benefit in that we understand so much more than we

otherwise would about this formidable foe called Mycoplasma.

 

Symptoms

 

The signs and symptoms of Mycoplasma infection are highly variable and

thus it is not uncommon for a diagnosis to be entirely missed. A partial list

of symptoms includes chronic fatigue, joint pain, intermittent fevers,

headaches, coughing, nausea, gastrointestinal problems, diarrhea, visual

disturbances, memory loss, sleep disturbances, skin rashes, joint stiffness,

depression, irritability, congestion, night sweats, loss of concentration,

muscle spasms, nervousness, anxiety, chest pain, breathing irregularities,

balance problems, light sensitivity, hair loss, problems with urination,

congestive heart failure, blood pressure abnormalities, lymph node pain,

chemical

sensitivities, persistent coughing, eye pain, floaters in the eyes, and

many others. On Dr. Nicolson's web site at http://www.immed.org, a full list

of signs and symptoms and an illness survey form can be found.

 

It doesn't take long to see that the symptoms of Mycoplasma infections are

very similar to the symptoms of Borrelia infections in chronic Lyme

disease. Dr. Nicolson has looked at some of the more common neurodegenerative

diseases and the infections that are associated with each. Mycoplasma is

commonly found in patients with ALS, Multiple Sclerosis, Autism, Chronic

Fatigue

Syndrome, Rheumatoid Arthritis, Chronic Asthma, Lyme disease, and many

other chronic disease conditions.

 

Characteristics

 

Mycoplasma are pleomorphic bacteria which lack a cell wall and, as a

result, many antibiotics are not effective against this type of bacteria. There

are over 100 known species of Mycoplasma, but only a half dozen or so are

known to be pathogenic in humans. The pathogenic species are intracellular

and must enter cells to survive. Once they are inside the cells, they are

not recognized by the immune system and it is difficult to mount an effective

response.

 

They stimulate reactive-oxygen species (ROS) which damage cell membranes.

They release toxins into the body. Infected cells can be stimulated to

undergo programmed cell death which may result in ALS or other severe

neurological presentations. 90% of ALS patients evaluated were found to have

Mycoplasma infections, whereas Mycoplasma was found in 100% of ALS patients

with

Gulf War Syndrome, almost all of which were weaponized M. fermentans

incognitus.

 

They are thought of as " borderline anaerobes " , meaning that they generally

prefer low oxygen environments. Dr. Nicolson has found that airline

employees are much more susceptible to these types of infections and that

symptoms worsen with frequent long flights at low oxygen tension. Mycoplasma

also

have some characteristics of viruses.

 

Mycoplasma tend to be slow growing infections and they are usually

transmitted slowly. Dr. Nicolson states that " Mycoplasma can be sexually

transmitted, but the infection is usually passed through far less intimate

contact.

Mycoplasma can be obtained through fluid exchange, and it is easily

transmitted through the air. " In Gulf War veterans, the first person besides

the

veteran to become ill was the spouse and, later, other members of the

household also became ill. Not everyone is equally susceptible to Mycoplasma

infections, especially those with strong immune systems who can resist

infection.

As already discussed, Mycoplasma fermentans produces numerous symptoms.

Those infected are rarely found to be asymptomatic. In North America, M.

pneumoniae is the most common Mycoplasma seen in various diseases. In Europe,

M. hominis is far more prevalent and the incidence of M. fermentans is much

lower than in North America.

The potential genetic factors involved in Mycoplasma illnesses are not

known. Those with immune deficiencies and other illnesses, such as cancers and

degenerative diseases, are at far greater risk of infection.

 

Prevalence

 

In one study looking at Mycoplasma in patients with Chronic Fatigue

Syndrome, Dr. Nicolson has observed some interesting patterns in his research.

Generally, the majority of CFS patients have Mycoplasma infections. However,

CFS patients infected with Borrelia burgdorferi, the punitive agent in Lyme

disease, had an even higher overall Mycoplasma infection rate. As many as

75% of Lyme disease patients appear to have Mycoplasma infections, and yet

Mycoplasma is often overlooked in the diagnosis and treatment of chronic

Lyme disease, neurodegenerative diseases, and many other chronic illnesses

lacking clear origins.

 

Even more startling was the finding that of the patients infected with

Borrelia, over 50% of the patients had the M. fermentans infection.

Approximately 23% carried M. pneumoniae.

 

Chronic Fatigue patients that did not test positive for Borrelia had much

more of a mixture of various species of Mycoplasma. Only 28% of the group

not co-infected with Lyme disease had the M. fermentans infection. In

normal, healthy controls, only 1.7% were found to have M. fermentans and at a

total Mycoplasma infection rate of 5% compared to the 75% group mentioned

earlier.

 

Dr. Nicolson notes that these findings are consistent with the fact that

it is the Mycoplasma fermentans species that is more often isolated in ticks

collected from the environment. The same tick that serves as the vector

for Borrelia burgdorferi often also transmits M. fermentans simultaneously.

Once a patient is multiply co-infected, the duration and severity of their

illness both increase.

 

In his experience, Dr. Nicolson has found that Mycoplasma is the number

one Lyme coinfection. The rate of infection with Mycoplasma in patients with

Lyme disease surpasses that of Bartonella (25-40%) slightly and that of

Babesia (8-20%) significantly.

 

According to Dr. Nicolson, a healthy immune system can generally clear M.

pneumoniae infections though will have a harder time eradicating M.

fermentans on its own. Healthy people can often hold these infections in check

-

essentially having the infection but not expressing symptoms.

 

 

Testing

 

Dr. Nicolson noted that Mycoplasma infections in chronic Lyme disease are

often overlooked by most doctors because they simply don't test for it. He

states that those that do test for it find a much higher number of infected

patients. Dr. Richard Horowitz, MD in New York finds a high incidence of

M. fermentans, according to Dr. Nicolson.

 

Sadly, however, even if patients are tested for Mycoplasma, a similar

problem exists here as the one that almost all Lyme doctors and patients are

aware of - namely that reliable tests do not exist. Dr. Nicolson notes that

once a laboratory gets a reliable test in place, the laboratory is often

shutdown. There are only a few labs left that test for Mycoplasma as a result.

 

In testing ticks for various microbial species, Dr. Nicolson has found a

very high incidence of Mycoplasma fermentans. However, other Mycoplasma

species have also been found such as M. pneumoniae and M. hominis. The

incidence of these other species is far lower. " Far and away " , it is the M.

fermentans species that is seen in ticks, and this probably reflects the high

incidence of M. fermentans coinfections in Lyme disease.

 

In terms of laboratory testing, Dr. Nicolson generally recommends Viral

Immune Pathology, formerly known as RedLabs. He has found that the usefulness

of any given lab in testing for Mycoplasma changes regularly. In the past,

Dr. Nicolson used Medical Diagnostic Laboratories (MDL) for testing, but

later he and other physicians found that the testing was no longer reliable.

As a result, he no longer recommends MDL.

Dr. Nicolson finds that laboratories testing for Mycoplasma are highly

scrutinized by federal agencies and that may affect the way the labs test and

report this type of infection.

 

Autoimmunity

 

Thomas McPherson Brown, MD studied Mycoplasma at the Rockefeller Institute

just before World War II. He was able to isolate bacteria from the joint

fluid of a person with autoimmune arthritis and believed that the infection

could have been the trigger for her disease. At the time, the organisms

were too small to identify precisely, but it was later determined to be

Mycoplasma.

 

Even then, Dr. Brown believed that Mycoplasma was very common and not easy

to eradicate. He suggested using tetracycline drugs as an effective

treatment for the disease. He later found that Doxycycline and Minocycline were

effective at dealing with Mycoplasma. Though he garnered praise from his

patients, he was generally regarded by the medical community as misguided and

a trouble-maker. He died in 1989 prior to being fully vindicated.

Fortunately, his work was validated through an NIH-sponsored study called MIRA

or

" Minocycline in Rheumatoid Arthritis " .

Due to many of the characteristics of Mycoplasma, they may be responsible

for the triggering of numerous autoimmune responses. As Mycoplasma

replicate within cells and are eventually released, they capture antigens from

the

surface of the host cell and incorporate these antigens into their own

membranes. This makes it almost impossible for the body to tell the difference

between good and bad, between human and microbe, or between us and them. As

a result, the immune system may begin to respond to these antigens now

incorporated into the cell walls of the bacteria and create a condition of

self-attack, or autoimmunity.

 

The microorganisms can produce mimicry antigens that mimic the natural

host surface antigens and trigger an immune response to these antigens which

may also result in autoimmune conditions through cross-reactivity.

Additionally, Mycoplasma may cause cell death of host cells through a process

known

as apoptosis or programmed cell death.

 

Treatment

 

Though various strains of Mycoplasma have their own unique characteristics

and drug responses, treatment tends to be quite similar. The variations in

the strains do not appear to be a factor in a successful treatment

response.

 

Dr. Nicolson suggests that in-vitro differences have been found but that

it is not possible to easily extrapolate these findings to an in-vivo

environment. Various factors including drug targeting, drug clearance, and the

ability for the drug to cross into various body compartments are important

considerations in treatment that cannot be examined in-vitro.

Dr. Nicolson believes that, like many other coinfections of Lyme disease,

Mycoplasma cannot be fully eradicated, but that once infected, treatment

becomes an ongoing " management approach " . He notes that this is a commonly

understood fact and that the same is true of other organisms such as

Chlamydia and Borrelia. Mycoplasma have the ability to go into a quiescent

phase in

intracellular locations within the body. Once in these locations, neither

antibiotics nor the immune system can effectively reach or kill the

organisms.

Many people recover from Mycoplasma infections and are fine for years.

They may later have an incident involving severe trauma or other significant

life stressor and symptoms fully reappear within weeks to months.

Dr. Nicolson recommends that the physician adopt an initial 6-month course

of treatment with no break followed by several 6-week on, 2-week off

antibiotic cycles. Candidate antibiotics include: Doxycycline, Ciprofloxacin

(Cipro), Azithromycin (Zithromax), Minocycline, or Clarithromycin (Biaxin). He

notes that antibiotic combinations may be required if there is a limited

response to single drug, and most patients require switching antibiotics at

least once during their treatment. Some patients may find the addition of

Flagyl to be a benefit to treatment.

In Gulf War patients, once effectively treated, the majority of patients

recovered. For civilians, six months is the minimum recommended treatment

length, and some patients require much longer treatment in order to recover.

Given that Mycoplasma have some characteristics of viruses, some

physicians have suggested that Famvir or Ganciclovir may be added to the

antibiotic

therapy.

 

Herxheimer reactions do occur when treating Mycoplasma infections. To

minimize this die-off effect where the patient generally feels much worse while

on treatment, Dr. Nicolson advises using 50mg oral Benadryl taken 30

minutes before the antibiotics. He also finds that a strained blend of 1 whole

lemon, 1 cup fruit juice, and 1 tablespoon of olive oil can be helpful.

Though Dr. Nicolson believes that antibiotics are the most effective

approach to treating Mycoplasma infections, he has found some good natural

options. In terms of natural approaches to treating Mycoplasma, Raintree

Nutrition (_http://www.rain-tree.com_ (http://www.rain-tree.com) ) has created

several products that may be quite helpful for patients. These include Raintree

Myco, Raintree A-F, and Raintree Immune Support.

 

Dr. Nicolson has seen evidence that Mycoplasma-specific transfer factors

such as those from Chisholm Labs and others can be beneficial in some

patients. He says that many natural options help in some patients, but that his

experience has been that the antibiotic treatment results in the best

outcomes. In many, recovery requires a push and pull between conventional and

alternative treatments.

 

One of the hallmark signs of Mycoplasma infection is fatigue. The

infections lead to oxidation in the body that leads to damage of the cell

membranes. Oxidation accelerates the damage to the lipids in cell membranes

which

impacts mitochondrial function. This leads to less energy in the cell and

ultimately to a fatiguing of the larger organism due to the fact that there is

less energy to support necessary cellular functions.

In patients where fatigue is due to cell membrane damage, Dr. Nicolson has

found NT Factor® to be highly beneficial. NT Factor® replaces the damaged

lipids and helps to restore mitochondrial function. Often, fatigue then

resolves or is reduced.

Dr. Nicolson has found that oxidative therapies such as ozone can be

helpful in the fight against Mycoplasma. However, he notes that this is

generally palliative and does not produce the same results as the antibiotic

therapy in the long-term. He finds that the oxidative therapies **are generally

more cytostatic than cytotoxic**. Hyperbaric oxygen may be helpful but

similarly does not appear to be a highly effective treatment in the

longer-term.

 

In other countries, IV drips with H2O2 (hydrogen peroxide) have been used

with some benefit, but Dr. Nicolson notes that these therapies, while

potentially effective, are highly dangerous and not advised.

In the realm of frequency medicine and Rife therapy, Dr. Nicolson believes

that the frequencies that could be used to address Mycoplasma are too

similar to normal cellular frequencies. Thus, he is not certain that Rife

therapy is an effective way to approach the problem.

 

In the nutritional realm, Dr. Nicolson finds that many patients with

chronic infections are immunosuppressed and that proper nutrition is vital. He

cautions against smoking and drinking. He suggests avoidance of sugars,

trans-fats, and allergenic foods. He advises patients to increase their fruits,

vegetables, and whole grains. Some dietary winners in supporting the

immune system include cruciferous vegetables, soluble fiber-based foods such as

prunes and bran, wheat germ, yogurt, fish, and whole grains.

Patients are often depleted in key vitamins and minerals. Supplementation

with B-Complex, Vitamin C, Vitamin E, and CoQ-10 are often beneficial.

Minerals are often necessary. Dr. Nicolson notes, however, that many people

have poor absorption and may require sublingual or injectable forms of these

nutrients. Amino acids, flax seed, and fish oils can provide additional

support, but the best nutrition for cell membranes is NT Factor®.

 

Many patients with chronic illnesses have a toxic body burden of heavy

metals such as mercury, lead, cadmium, and aluminum. Hair, stool, and urine

testing is available through labs like Doctor's Data

(_http://www.doctorsdata.com_ (http://www.doctorsdata.com) ) and Genova

Diagnostics

(_http://www.gdx.net_ (http://www.gdx.net) ). Dr. Nicolson has seen reports of

positive

results with EDTA chelation suppositories from Detoxamin

(_http://www.detoxamin.com_ (http://www.detoxamin.com) ) and oral chelators

from Longevity

Plus (_www.longevityplus.com_ (http://www.longevityplus.com) ).

 

For patients using antibiotics, beneficial gut flora is often depressed.

Supplementation with a high quality probiotic is important, but probiotics

have to be taken two hours or longer after taking antibiotics. Natural

immune support can be helpful in the form of whey proteins, transfer factors,

or

immune-support products such as Beyond Immuni-T from Longevity Plus.

 

Biolfims

 

Dr. Nicolson believes that biofilms are a factor in successfully treating

Mycoplasma infections. In cases that are refractory to antibiotics,

biofilms are likely a major factor.

 

In men with chronic refractory prostatitis which is infection-based, one

often cannot be treated effectively with antibiotics. However, when

Detoxamin (EDTA) or other agents to address the biofilms are used, it then

becomes

possible to treat these infections with tetracyclines. Patients quickly

show functional increases and decreases in pain other symptoms.

 

 

Summary

 

In chronic Lyme disease, it is often difficult to know which infections

are actually responsible for the persistence of illness. However, in general

terms, chronic intracellular infections that change the metabolism of cells

and suppress mitochondrial and other functions will lead to patients

remaining in a chronically ill state. Dr. Nicolson believes that these

infections must be aggressively treated. **Similar to chronic Lyme disease, the

current CDC or IDSA recommendations for short-term treatment of chronic

infections are simply inadequate,** he says.

Dr. Nicolson has found that there is a hierarchy of symptoms that resolve

relatively quickly and those that resolve more slowly when treating

Mycoplasma. Gut-associated phenomenon such as Irritable Bowel Syndrome (IBS)

often

resolve quickly. Other systemic signs and symptoms can resolve in an inter

mediate period of time from many weeks to many months. Symptoms associated

with the central and peripheral nervous systems such as neuropathy and pain

often resolve much more slowly. Skin sensitivity and burning sensations may

take much longer to resolve. Mycoplasma infections do invade nerves, and

nerve-related symptoms are among the more difficult to resolve.

 

Dr. Nicolson states **We keep seeing the suppression of information on

Mycoplasma and similar intracellular bacterial infections. The world of

Mycoplasma parallels the world of chronic Lyme disease in terms of the politics

involved. Physicians are being persecuted by their medical boards as a

result of bad information. It is important for us to do everything within our

power to get rid of harmful, erroneous information about these diseases. Both

Mycoplasma and Borrelia have been manipulated for biological weapons

purposes and as a result, both are politically incorrect to discuss, work on,

or

do anything about. Until this changes, we won*t see any real progress.**

 

 

Scott Forsgren is the editor and founder of the website

BetterHealthGuy.com where he shares his twelve year journey through a chronic

illness only

diagnosed as Lyme disease after eight years of searching for answers. Scott

can be reached at Scott.

 

Additional information on NT Factor® can be found at

www.ntfactor.com or _www.researchednutritionals.com_

(http://www.researchednutritionals.com/) .